Index of substances - Janusmed Sex and Gender

a b c d e f g h i j k l m n o p q r s t u v w x y z å ä ö 0 1 2 3 4 5 6 7 8 9

Substances (601)

abacavir hydrochloride monohydrate

abacavir sulfate

acamprosate calcium

acetylsalicylic acid, low-dose

aclidinium bromide

adenovirus serotype 26 (Ad26) vector, encoding SARS-CoV-2 spike protein, recombinant

agomelatine citric acid

agomelatine urea

alendronate sodium

alendronate sodium anhydrous

alendronate sodium monohydrate

alendronic acid

alimemazine hemitartrate

amitriptyline chloride

amlodipine besylate

amlodipine maleate

amlodipine mesilate

amlodipine mesylate monohydrate

amoxicillin sodium

amoxicillin trihydrate

ampicillin sodium

ampicillin trihydrate

atazanavir sulfate

atomoxetine hydrochloride

atorvastatin calcium

atorvastatin calcium amorphous

atorvastatin calcium isopropanolate

atorvastatin calcium propylene glycol solvate

atorvastatin calcium trihydrate

azithromycin dihydrate

azithromycin monohydrate

baloxavir marboxil

beclometasone dipropionate anhydrous

beclometasone dipropionate monohydrate

bendroflumethiazide

bisoprolol fumarate

bromocriptine mesylate

buprenorphine hydrochloride

caffeine citrate

caffeine monohydrate

candesartan cilexetil

cefotaxime sodium

ceftazidime pentahydrate

chimpanzee adenovirus vector, encoding SARS-CoV-2 spike protein, recombinant

cholecalciferol

cilastatin sodium

ciprofloxacin hydrochloride

ciprofloxacin hydrochloride monohydrate

ciprofloxacin hydrogensulfate

ciprofloxacin lactate

clavulanate potassium

clavulanic acid

clopidogrel besylate

clopidogrel hydrobromide monohydrate

clopidogrel hydrochloride

clopidogrel hydrogensulphate

compap pvp3 (code 3930)

cyanocobalamin (Co-57)

cyanocobalamin 1% sd (no.307420)

cyanocobalamin tannin complex

dabigatran etexilate

dabigatran etexilate mesylate

darunavir ethanolate

darunavir propylene glycol solvate

diclofenac diethylamine

diclofenac epolamine

diclofenac potassium

diclofenac sodium

dimethyl fumarate

donepezil hydrochloride

donepezil hydrochloride monohydrate

doxazosin mesylate

doxycycline caragenate

doxycycline hyclate

doxycycline hydrochloride

doxycycline monohydrate

dronedarone hydrochloride

dry vitamin D3 100 CWS (BASF)

dry vitamin d3 100 sd/s

dry vitamin D3 50 CWS

edoxaban tosilate monohydrate

entecavir monohydrate

eprosartan mesylate

erythromycin acistrate

erythromycin estolate

erythromycin ethyl carbonate

erythromycin ethylsuccinate

erythromycin gluceptate

erythromycin lactobionate

erythromycin propionate

erythromycin stearate

erythromycin stinoprate

erythromycin thiocyanate

esomeprazole magnesium

esomeprazole magnesium dihydrate

esomeprazole magnesium trihydrate

esomeprazole sodium

fentanyl citrate

fentanyl hydrochloride

fesoterodine fumarate

fluocinolone acetonide

fluoxetine hydrochloride

fluticasone furoate

fluticasone propionate

folic acid hydrated

formoterol fumarate dihydrate

furosemide sodium

galantamine hydrobromide

gentamicin sulphate

glycopyrronium bromide

glycopyrronium tosilate monohydrate

hydrochlorothiazide

hydrocortisone aceponate

hydrocortisone acetate

hydrocortisone buteprate

hydrocortisone butyrate

hydrocortisone sodium phosphate

hydrocortisone sodium succinate

ibuprofen arginate

ibuprofen D,L-lysine

ibuprofen DC 85

ibuprofen sodium dihydrate

imipenem monohydrate

indacaterol acetate

indacaterol maleate

influenza a/california/7/2009 (h1n1)v-like strain, inactivated antigen

influenza b/florida/4/2006-like strain b/brisbane/3/2007

influenza virus

influenza virus A (H1N1), live attenuated

influenza virus A (H1N1)-like strain, surface antigen, inactivated

influenza virus A (H3N2), live attenuated

influenza virus A (H3N2)-like strain, surface antigen, inactivated

influenza virus A/Brisbane/02/2018 (H1N1)pdm09-like strain (A/Brisbane/02/2018, IVR-190), split virion, inactivated

influenza virus A/Brisbane/02/2018 (H1N1)pdm09-like strain (A/Brisbane/02/2018, IVR-190), surface antigen, inactivated

influenza virus A/Brisbane/02/2018 (H1N1)pdm09-like strain (A/Switzerland/3330/2017, MEDI 307134), live attenuated

influenza virus A/Brisbane/10/2007 (H3N2)-like strain (A/Uruguay/716/2007, NYMC X-175C), surface antigen, inactivated

influenza virus A/Brisbane/59/2007 (H1N1)-like strain (A/Brisbane/59/2007, IVR-148), surface antigen, inactivated

influenza virus A/California/7/2004 (H3N2)-like strain (A/New York/55/2004 (NYMC X-157)), surface antigen, inactivated

influenza virus A/California/7/2009 (H1N1) pdm09 - like strain (A/California/7/2009, NYMC X-181), split virion

influenza virus A/California/7/2009 (H1N1)-derived strain (NYMC X-181), split virion, inactivated

influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-179A), split virion, inactivated

influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-181), split virion, inactivated

influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-181), surface antigen, inactivated

influenza virus A/California/7/2009 (H1N1)pdm09-like strain (A/Bolivia/559/2013, MEDI 255962), live attenuated

influenza virus A/California/7/2009 (H1N1)pdm09-like strain (A/California/7/2009, MEDI 228029), live attenuated

influenza virus A/California/7/2009 (H1N1)pdm09-like strain (A/California/7/2009, X-181), surface antigen, inactivated

influenza virus A/California/7/2009 (H1N1)pdm09-like strain (NIB-74xp, derived from A/Christchurch/16/2010), split virion, inactivated

influenza virus A/California/7/2009 (H1N1)v, whole virion, inactivated, prepared in cell cultures

influenza virus A/California/7/2009 (H1N1)v-like strain (NYMC X-179A), split virion, inactivated

influenza virus A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Cambodia/e0826360/2020, IVR-224), surface antigen, inactivated

influenza virus A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, IVR-221), split virion, inactivated

influenza virus A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, MEDI 339018), live attenuated

influenza virus A/Darwin/9/2021 (H3N2)-like stam (A/Darwin/6/2021, IVR-227), surface antigen, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), split virion, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-228), split virion, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, IVR-227), surface antigen, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010), split virion, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010), surface antigen, inactivated

influenza virus A/Darwin/9/2021 (H3N2)-like strain (A/Norway/16606/2021, MEDI 355293), live attenuated

influenza virus A/Fujian/411/2002 (H3N2)-like strain (A/Wyoming/3/2003 X-147), inactivated antigen

influenza virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909), surface antigen, inactivated

influenza virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909), surface antigen, inactivated, human

influenza virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like strain (A/Hawaii/66/2019, MEDI 326775), live attenuated

influenza virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like strain (A/Victoria/2454/2019 IVR-207), surface antigen, inactivated, human

influenza virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) pdm09-like strain (A/Victoria/2454/2019, IVR-207), split virion, inactivated

influenza virus A/Hong Kong/2671/2019 (H3N2) - like strain (A/Hong Kong/2671/2019, IVR-208), split virion, inactivated

influenza virus A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019 IVR-208), surface antigen, inactivated

influenza virus A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, MEDI 325078), live attenuated

influenza virus A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, NIB-121), split virion, inactivated

influenza virus A/Hong Kong/4801/2014 (H3N2)-like strain (A/Hong Kong/4801/2014, NYMC X-263B), split virion, inactivated

influenza virus A/Hong Kong/4801/2014 (H3N2)-like strain (A/Hong Kong/4801/2014, X-263B), surface antigen, inactivated

influenza virus A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, MEDI 263122), live attenuated

influenza virus A/Indonesia/05/2005 (H5N1)-like strain (PR8-IBCDC-RG2), split virion, inactivated

influenza virus A/Kansas/14/2017 (H3N2)-like strain (A/Kansas/14/2017, MEDI 308763), live attenuated

influenza virus A/Kansas/14/2017 (H3N2)-like strain (A/Kansas/14/2017, NYMC X-327), split virion, inactivated

influenza virus A/Kansas/14/2017 (H3N2)-like strain (A/Kansas/14/2017, NYMC X-327), surface antigen, inactivated

influenza virus A/Michigan/45/2015 (H1N1)pdm09-like strain (A/Singapore/GP1908/2015, IVR-180), surface antigen, inactivated

influenza virus A/Michigan/45/2015 (H1N1)pdm09-like strain (A/Slovenia/2903/2015, MEDI 279432), live attenuated

influenza virus A/Michigan/45/2015(H1N1)pdm09-like strain (A/Michigan/45/2015,NYMC X-275), split viron, inactivated

influenza virus A/Moscow/10/99(H3N2)-like strain (A/Panama/2007/99 (RESVIR-17)), surface antigen, inactivated

influenza virus A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated

influenza virus A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009), split virion, inactivated, prepared in cell cultures

influenza virus A/Perth/16/2009 (H3N2)-like strain (NYMC X-187, derived from A/Victoria/210/2009), split virion, inactivated

influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2)-like strain (A/Singapore/INFIMH-16-0019/2016, IVR-186), split virion, inactivated

influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2)-like strain (A/Singapore/INFIMH-16-0019/2016, IVR-186), surface antigen, inactivated

influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2)-like strain (A/Singapore/INFIMH-16-0019/2016, MEDI 291690) live attenuated

influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2)-like strain (A/Singapore/INFIMH-16-0019/2016, NIB-104), surface antigen, inactivated

influenza virus A/Switzerland/9715293/2013 (H3N2) - like strain (A/South Australia/55/2014, IVR-175, split virion

influenza virus A/Switzerland/9715293/2013 (H3N2) - like strain (A/Switzerland/9715293/2013, MEDI 252385), live attenuated

influenza virus A/Switzerland/9715293/2013 (H3N2) - like strain (A/Switzerland/9715293/2013, NIB-88), split virion, inactivated

influenza virus A/Switzerland/9715293/2013 (H3N2) - like strain (A/Switzerland/9715293/2013, NIB-88), surface antigen, inactivated

influenza virus A/Texas/50/2012 (H3N2)-derived strain (NYMC X-223A), split virion, inactivated

influenza virus A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012, MEDI 237514) live attenuated

influenza virus A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012, X-223A), surface antigen, inactivated

influenza virus A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022), split virion, inactivated

influenza virus A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022), surface antigen, inactivated

influenza virus A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, IVR-237), split virion, inactivated

influenza virus A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, MEDI 370626), live attenuated

influenza virus A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/1/2020, MEDI 340505), live attenuated

influenza virus A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215), split virion, inactivated

influenza virus A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215), surface antigen, inactivated

influenza virus A/Victoria/361/2011 (H3N2)-derived strain (IVR-165), split virion, inactivated

influenza virus A/Victoria/361/2011 (H3N2)-like strain (A/Victoria/361/2011, MEDI 231411), live attenuated

influenza virus A/Victoria/361/2011 (H3N2)-like strain (NYMC X-223, derived from A/Texas/50/2012), surface antigen, inactivated

influenza virus A/Victoria/361/2011 (H3N2)-like strain (NYMC X-223A, derived from A/Texas/50/2012), split virion, inactivated

influenza virus A/Victoria/361/2011 (H3N2)-like strain (NYMC X-223A, derived from A/Texas/50/2012), surface antigen, inactivated

influenza virus A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Norway/31694/2022, MEDI 369815), live attenuated

influenza virus A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238), split virion, inactivated

influenza virus A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238), surface antigen, inactivated

influenza virus A/Vietnam/1194/2004 (H5N1)-like strain (NIBRG-14), surface antigen, inactivated

influenza virus A/Vietnam/1203/2004 (H5N1), whole virion, inactivated, prepared in cell cultures

influenza virus B, live attenuated

influenza virus B, Victoria lineage, live attenuated

influenza virus B, Yamagata lineage, live attenuated

influenza virus B-like strain (Victoria lineage), surface antigen, inactivated

influenza virus B-like strain (Yamagata lineage), surface antigen, inactivated

influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26), split virion, inactivated

influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26), surface antigen, inactivated

influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, MEDI 355292), live attenuated

influenza virus B/Austria/1359417/2021-like strain (B/Michigan/01/2021, wild type), split virion, inactivated

influenza virus B/Brisbane/60/2008 (Victoria lineage)-like strain (B/Brisbane/60/2008, MEDI 228030), live attenuated

influenza virus B/Brisbane/60/2008, split virion, inactivated

influenza virus B/Brisbane/60/2008-derived strain (NYMC BX-35), inactivated antigen

influenza virus B/Brisbane/60/2008-like strain (B/Brisbane/60/2008), surface antigen, inactivated

influenza virus B/Brisbane/60/2008-like strain (B/Brisbane/60/2008, wild type), split virion, inactivated

influenza virus B/Brisbane/60/2008-like strain (B/Brisbane/60/2008, wild type), surface antigen, inactivated

influenza virus B/Brisbane/9/2014 (wild type), surface antigen, inactivated

influenza virus B/Colorado/06/2017-like strain (B/Maryland/15/2016, NYMC BX-69A), split virion, inactivated

influenza virus B/Colorado/06/2017-like strain (B/Maryland/15/2016, NYMC BX-69A), surface antigen, inactivated

influenza virus B/Colorado/062017-like strain (B/Colorado/06/2017, MEDI 293454), live attenuated

influenza virus B/Florida/4/2006-like strain (B/Florida/4/2006), surface antigen, inactivated

influenza virus B/harbin/7/94

influenza virus B/Hong Kong/330/2001-like strain (B/Shangdong/7/79), split virion, inactivated

influenza virus B/Massachusetts/2/2012 (Yamagata lineage)-like strain (B/Massachusetts/2/2012, MEDI 237751), live attenuated

influenza virus B/Massachusetts/2/2012, split virion, inacivated

influenza virus B/Massachusetts/2/2012-derived strain (NYMC BX-51B), split virion, inactivated

influenza virus B/Massachusetts/2/2012-derived strain (NYMC BX-51B), surface antigen, inactivated

influenza virus B/Massachusetts/2/2012-like strain (B/Massachusetts/2/2012, wild type), surface antigen, inactivated

influenza virus B/Phuket/3073/2013

influenza virus B/Phuket/3073/2013 (Yamagata lineage) like strain (B/Phuket/3073/2013, MEDI 254977), live attenuated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, B Yamagata lineage), split virion, inactivated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B), split virion, inactivated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B), surface antigen, inactivated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, MEDI 306444), live attenuated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type), split viron, inactivated

influenza virus B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type), surface antigen, inactivated

influenza virus B/Shanghai/361/2002 - like strain (B/Jiangsu/10/2003), surface antigen, inactivated

influenza virus B/Washington/02/2019-like strain (B/Victoria/705/2018 BVR-11), surface antigen, inactivated

influenza virus B/Washington/02/2019-like strain (B/Victoria/705/2018, BVR-11), split virion, inactivated

influenza virus B/Washington/02/2019-like strain (B/Washington/02/2019, MEDI 323797), live attenuated

influenza virus B/Washington/02/2019-like strain (B/Washington/02/2019, wild type), split virion, inactivated

influenza virus B/Washington/02/2019-like strain (B/Washington/02/2019, wild type), surface antigen, inactivated

influenza virus B/Washington/02/2019-like strain (Victoria lineage), split virion, inactivated

influenza virus B/Wisconsin/1/2010-like strain (B/Wisconsin/1/2010, MEDI 028507), live attenuated

influenza virus B/Wisconsin/1/2010-like strain (NYMC BX-39, derived from B/Hubei-Wujiagang/158/2009), split virion, inactivated

insulin aspart protamine

insulin glargine

insulin glulisine

insulin human amorph

insulin human cristalline

insulin human isophan

insulin human soluble

insulin lispro (soluble)

insulin lispro protamin

interferon beta-1a

ipratropium bromide

ipratropium bromide monohydrate

ketorolac trometamol

L1 protein, human papillomavirus (HPV) type 11, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 16, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 18, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 31, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 33, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 45, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 52, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 58, virus-like particles, recombinant

L1 protein, human papillomavirus (HPV) type 6, virus-like particles, recombinant

labetalol hydrochloride

lidocaine hydrochloride

lidocaine hydrochloride monohydrate

lisdexamfetamine

lisdexamfetamine dimesilate

lithium carbonate

lithium chloride

lithium citrate

lithium sulfate

lithium sulfate anhydrous

losartan potassium

memantine hydrochloride

meropenem trihydrate

metforminhydrochloride

methadone hydrochloride

methylprednisolone

methylprednisolone acetate

methylprednisolone sodium succinate

metoclopramide hydrochloride

metoclopramide hydrochloride monohydrate

metoprolol succinate

metoprolol tartrate

metronidazole benzoate

mometasone furoate

mometasone furoate monohydrate

montelukast sodium

naltrexone hydrochloride

naproxen sodium

nitrofurantoin monohydrate

olodaterol hydrochloride

omeprazole magnesium

omeprazole sodium

ondansetron hydrochloride

ondansetron hydrochloride dihydrate

oxycodone hydrochloride

pantoprazole sodium anhydrous

pantoprazole sodium hydrate

Paracetamol DC (PVP) 284N

peginterferon alfa-2a

perampanel hydrate

phenobarbital sodium

piperacillin sodium

Plantago ovata (ispaghula), husk

Plantago ovata (ispaghula), husk, powder

podophyllotoxin

pramipexole dihydrochloride monohydrate

prasugrel besilate

prasugrel hydrochloride

pravastatin sodium

prednisolone acetate

prednisolone caproate

prednisolone pivalate

prednisolone sodium phosphate

prednisolone sodium succinate

prilocaine hydrochloride

promethazine hydrochloride

propylthiouracil

raltegravir potassium

ranitidine hydrochloride

rasagiline mesilate

rasagiline tartrate

reboxetine mesylate

retinol acetate

retinol palmitate

retinyl propionate

rilpivirine hydrochloride

rivastigmine tartrate

rizatriptan benzoate

ropinirole hydrochloride

rosuvastatin calcium

sacubitril valsartan sodium hydrate

salbutamol sulfate

salmeterol xinafoate

sertraline hydrochloride

sevelamer carbonate

sevelamer hydrochloride

sodium picosulfate

sodium picosulfate anhydrous

sodium picosulfate monohydrate

sulfamethoxazole

sumatriptan succinate

tazobactam sodium

tenofovir alafenamide

tenofovir alafenamide hemifumarate

tenofovir disoproxil

tenofovir disoproxil fumarate

tenofovir disoproxil maleate

tenofovir disoproxil phosphate

tenofovir disoproxil succinate

terbinafine hydrochloride

terbutaline sulfate

teriparatide (synthetic)

timolol maleate

tiotropium bromide

tiotropium bromide monohydrate

tramadol hydrochloride

umeclidinium bromide

valsartan sodium

vancomycin hydrochloride

venlafaxine hydrochloride

verapamil hydrochloride

vitamin b12 0.1 % sd

vitamin b12 0.1% (no.303 075/1-82)

vitamin d3 100 CWS

vortioxetine hydrobromide

vortioxetine lactate

warfarin sodium

ziprasidone hydrochloride

ziprasidone hydrochloride monohydrate

ziprasidone hydrogensulfate dihydrate

ziprasidone mesylate

zoledronic acid

zoledronic acid hemipentahydrate

zoledronic acid monohydrate

zoledronic acid trihydrate

Documents (228)

Acetylsalicylic acid - low-dose

Baloxavir marboxil

Bendroflumethiazide

Budesonide – intranasal

Budesonide – local effect in colon

Budesonide – oral inhalation

Cladribine – intravenous

Cladribine – oral

Dimethyl fumarate

Fluocinolone – intravitreal

Fluticasone – inhalation

Fluticasone – nasal spray

Fluticasone – topical

Hydrochlorothiazide

Hydrocortisone – systemic use

Insulin glargine

Insulin glulisine

Interferon beta-1a (intramuscular)

Interferon beta-1a (subcutaneous)

Ivermectin - systemic use

Ivermectin - topical

Lidocaine – topical

Lisdexamfetamine

Methylprednisolone

Metronidazole – systemic use

Metronidazole – topical

Peginterferon alfa-2a

Piperacillin + enzyme inhibitor

Podophyllotoxin

Prednisolone – systemic use

Propylthiouracil

Sacubitril + valsartan

Sodium picosulphate

Terbinafine – systemic use

Trimethoprim + sulfamethoxazole

Vaccine against COVID-19 (adenovirus vector)

Vaccine against COVID-19 (mRNA)

Vaccine against influenza

Vaccine for human papillomavirus (types 16 and 18)

Vaccine for human papillomavirus (types 6, 11, 16, 18)

Vaccine for human papillomavirus (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)

Vitamin A (retinol)

Vitamin B12 (cyanocobalamin and derivates)

Vitamin D3 (cholecalciferol)

Zoledronic acid